Training addiction counselors to deliver a brief psychoeducational intervention for chronic pain among patients in opioid agonist treatment: A pilot investigation

被引:7
|
作者
Butner, Jenna L. [1 ,2 ]
Bone, Curtis [1 ,2 ]
Ponce Martinez, Caridad C. [2 ,3 ]
Kwon, Grace [2 ,3 ]
Beitel, Mark [2 ,3 ]
Madden, Lynn M. [2 ,3 ]
Bono, Madeline H. [2 ,4 ]
Eller, Anthony [2 ,5 ]
Barry, Declan T. [2 ,3 ]
机构
[1] Yale Sch Med, Dept Internal Med, New Haven, CT USA
[2] APT Fdn Inc, Pain Treatment Serv, New Haven, CT USA
[3] Yale Sch Med, Dept Psychiat, New Haven, CT USA
[4] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA
[5] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA
关键词
Academic training; buprenorphine; counseling; counselor; methadone; opioid-related disorders; pain; psychoeducation; METHADONE-MAINTENANCE TREATMENT; DEPENDENT INDIVIDUALS; UNITED-STATES; MANAGEMENT; EDUCATION; GUIDELINE;
D O I
10.1080/08897077.2018.1449052
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Despite high rates of chronic pain among their patients, opioid agonist treatment (OAT) counselors report an absence of training to manage chronic pain. Methods: A multidisciplinary team developed a tailored training for counselors to screen and address chronic pain via a brief psychosocial intervention, and implemented it with 52 addiction counselors. Data on knowledge (9 true-false items) as well as attitudes, interest, and perceived ability (scored on 5-point Likert-type scales) were collected from counselors before (pre-test), after (post-test) training, and after 6 months (follow-up). Results: Pre-test knowledge scores varied considerably. Compared to pre-test, mean counselor knowledge scores increased significantly post-training and at follow-up (ps < .05). The training was associated with increases in positive attitudes toward the role of counselors in managing chronic pain, interest in assessing chronic pain, and counselor ability to assess as well as suggest appropriate interventions for pain (all ps < .05). Perceived ability to assess chronic pain and suggest appropriate treatment interventions were higher at follow-up than at pre-test (ps < .05). Conclusions: Findings related to the initial evaluation of this training were promising, and future research is warranted to further examine the efficacy of training drug counselors on psychosocial interventions to manage chronic pain among OAT patients.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 50 条
  • [41] Utilization and disparities in medication treatment for opioid use disorder among patients with comorbid opioid use disorder and chronic pain during the COVID-19 pandemic
    Perry, Allison
    Wheeler-Martin, Katherine
    Hasin, Deborah S.
    Terlizzi, Kelly
    Mannes, Zachary L.
    Jent, Victoria
    Townsend, Tarlise N.
    Ii, John R. Pamplin
    Crystal, Stephen
    Martins, Silvia S.
    Cerd, Magdalena
    Krawczyk, Noa
    DRUG AND ALCOHOL DEPENDENCE, 2023, 253
  • [42] Brief family treatment intervention to promote aftercare among male substance abusing patients in inpatient detoxification: A quasi-experimental pilot study
    O'Farrell, Timothy J.
    Murphy, Marie
    Alter, Jane
    Fals-Stewart, William
    ADDICTIVE BEHAVIORS, 2007, 32 (08) : 1681 - 1691
  • [43] Effectiveness of long-term opioid therapy among chronic non-cancer pain patients attending multidisciplinary pain treatment clinics: A Quebec Pain Registry study
    Saidi, Hichem
    Page, M. Gabrielle
    Boulanger, Aline
    Ware, Mark A.
    Choiniere, Manon
    CANADIAN JOURNAL OF PAIN-REVUE CANADIENNE DE LA DOULEUR, 2018, 2 (01): : 113 - 124
  • [44] Co-Designing a Digital Brief Intervention to Reduce the Risk of Prescription Opioid-Related Harm Among People With Chronic Noncancer Pain: Qualitative Analysis of Patient Lived Experiences
    Elphinston, Rachel A.
    Pager, Sue
    Brown, Kelly
    Sterling, Michele
    Fatehi, Farhad
    Gray, Paul
    Hipper, Linda
    Cahill, Lauren
    Connor, Jason P.
    JMIR FORMATIVE RESEARCH, 2025, 9
  • [45] A randomized pilot trial of two forms of behavioral economics intervention to improve engagement in buprenorphine-naloxone treatment among patients with opioid use disorder
    Derefinko, Karen J.
    Thomas, Fridtjof
    Peter, Samuel C.
    Murphy, James G.
    Witkiewitz, Katie
    Cowan, Ron
    Harris, Matt
    Hand, Sarah
    Johnson, Karen C.
    DRUG AND ALCOHOL DEPENDENCE, 2025, 268
  • [46] Opioid Use Disorders among Patients on Long-Term Morphine for Management of Chronic Cancer Pain: A Pilot Study from a Tertiary Palliative Care Facility
    Choudhary, Nandan
    Singh, Shalini
    Rathore, Puneet
    Ambekar, Atul
    Bhatnagar, Sushma
    INDIAN JOURNAL OF PALLIATIVE CARE, 2021, 27 (02) : 264 - 268
  • [47] PHYSICAL HEALTH AND UTILISATION OF ALCOHOL AND OTHER DRUG TREATMENT AMONG A SAMPLE OF CHRONIC NON-CANCER PAIN PATIENTS DEPENDENT ON THEIR OPIOID MEDICATION
    Moore, Teleri
    O'Donnell, Courtney
    Degenhardt, Louisa
    Campbell, Gabrielle
    Nielsen, Suzanne
    Larance, Briony
    DRUG AND ALCOHOL REVIEW, 2016, 35 : 55 - 56
  • [48] The efficacy of buprenorphine/naloxone as a pain relief agent in patients self-identified as having comorbid chronic pain who are being treated in a general office-based opioid addiction treatment program
    Sullivan, C. R.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2015, 84 : 69 - 70
  • [49] Changing BSN Students' Stigma Toward Patients Who Use Alcohol and Opioids Through Screening, Brief Intervention, and Referral to Treatment (SBIRT) Education and Training: A Pilot Study
    Mahmoud, Khadejah F.
    Lindsay, Dawn
    Scolieri, Britney B.
    Hagle, Holly
    Puskar, Kathryn R.
    Mitchell, Ann M.
    JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2018, 24 (06) : 510 - 521
  • [50] Assessment of opioid analgesics addiction in patients with non-cancerous chronic pain followed at a center for pain assessment and treatment using a substance use disorders questionnaire derived from DSM-V criteria
    Eiden, C.
    Ginies, P.
    Nogue, E.
    Damdjy, Y.
    Picot, M. C.
    Donnadieu-Rigole, H.
    Peyriere, H.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 29 - 29